CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 58 enrolled
Drug / intervention
Erchonia FX-635 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02538523
NCT02538523N/ACompleted
CompareCT.gov

A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia FX-635 on Low Back Pain

Erchonia Corporation·interventional·Posted Sep 2, 2015·Updated Jun 10, 2021

In Brief

A clinical study evaluating Erchonia FX-635 and Placebo Laser for Low Back Pain. Completed, enrolled 58 participants across 3 sites.

Detailed Summary

This study evaluates the effect of low level laser light therapy on reducing low back pain. Half of the participants will receive the actual treatment with the active laser and the other half of the participants will receive a placebo treatment with an inactive laser.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLow Back Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 2, 2015
Enrollment StartApr 8, 2016
Primary CompletionOct 7, 2017
Study CompletionDec 10, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 10.8 years ago

Interventions

Erchonia FX-635device

The Erchonia FX-635 is applied to the lower back and hips area for 20 minutes per treatment administration, 8 times across 4 weeks, 2 times per week.

Placebo Laserdevice

The Placebo Laser is applied to the lower back and hips area for 20 minutes per treatment administration, 8 times across 4 weeks, 2 times per week.